← Browse by Condition
Medical Condition
thrombocytopenia
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4, Phase 2
ClinicalMetric tracks all active clinical trials for thrombocytopenia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — thrombocytopenia Clinical Trials
How many clinical trials are currently recruiting for thrombocytopenia?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for thrombocytopenia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for thrombocytopenia?
thrombocytopenia research spans Phase 2 (3 trials), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a thrombocytopenia clinical trial?
Eligibility criteria for thrombocytopenia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2 3
Phase 4 1
Top Sponsors
2 trials
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04800458
Recruiting
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
Enrollment
225 pts
Location
France
Sponsor
University Hospital, Bordeaux
NCT06562738 Phase 4
Recruiting
Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia
Enrollment
55 pts
Location
China
Sponsor
The Third People's Hospital of...
NCT05983952 Phase 2
Recruiting
Anti-CD38 Antibody Treating APS With Thrombocytopenia
Enrollment
10 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
NCT07441720 Phase 2
Recruiting
Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)
Enrollment
25 pts
Location
China
Sponsor
Zhejiang Cancer Hospital
NCT07616349
Recruiting
Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.
Enrollment
85 pts
Location
Spain
Sponsor
Nicolas Brogly
NCT05199909 Phase 2
Recruiting
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Enrollment
10 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology